• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is high-dose radioimmunotherapy needed in non-Hodgkin's lymphoma? For.

作者信息

Behr Thomas M

机构信息

Department of Nuclear Medicine of the Philipps-University of Marburg, Baldingerstrasse, 35043 Malburg, Germany.

出版信息

Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1248-54. doi: 10.1007/s00259-002-0928-9.

DOI:10.1007/s00259-002-0928-9
PMID:12418465
Abstract
摘要

相似文献

1
Is high-dose radioimmunotherapy needed in non-Hodgkin's lymphoma? For.非霍奇金淋巴瘤需要高剂量放射免疫疗法吗？针对……
Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1248-54. doi: 10.1007/s00259-002-0928-9.
2
Is high-dose radioimmunotherapy needed in non-Hodgkin's lymphoma? Against.非霍奇金淋巴瘤是否需要高剂量放射免疫疗法？反对。
Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1254-6. doi: 10.1007/s00259-002-0929-8.
3
Radioimmunotherapy for non-Hodgkin's lymphoma.非霍奇金淋巴瘤的放射免疫疗法。
Clin Cancer Res. 2004 Dec 1;10(23):7789-91. doi: 10.1158/1078-0432.CCR-04-1706.
4
Impact of nodal regression on radiation dose for lymphoma patients after radioimmunotherapy.放射免疫治疗后淋巴瘤患者淋巴结消退对辐射剂量的影响。
J Nucl Med. 2003 Aug;44(8):1322-9.
5
[Indications for radioimmunotherapy for patients with non-Hodgkin's lymphoma].[非霍奇金淋巴瘤患者放射免疫治疗的适应证]
Ugeskr Laeger. 2011 May 16;173(20):1417-21.
6
Importance of pre-treatment radiation absorbed dose estimation for radioimmunotherapy of non-Hodgkin's lymphoma.非霍奇金淋巴瘤放射免疫治疗中预处理辐射吸收剂量估计的重要性。
Nucl Med Biol. 1997 Oct;24(7):635-8. doi: 10.1016/s0969-8051(97)00098-x.
7
The expanding frontier of radioimmunotherapy of relapsed Non-hodgkin's lymphoma.复发性非霍奇金淋巴瘤放射免疫治疗的前沿拓展
Clin Lymphoma. 2000 Sep;1(2):158-9. doi: 10.1016/s1526-9655(11)70208-1.
8
Durable responses reported with radioimmunotherapy in low-grade non-Hodgkin's lymphoma.放射性免疫疗法治疗低度非霍奇金淋巴瘤有持久缓解的报道。
Oncology (Williston Park). 2002 Mar;16(3):304, 326.
9
Radioimmunotherapy of non-Hodgkin's lymphoma revisited.非霍奇金淋巴瘤的放射免疫治疗再探讨。
J Nucl Med. 2005 Feb;46(2):383-4.
10
Ongoing investigations and new uses of radioimmunotherapy in the treatment of non-Hodgkin's lymphoma.放射免疫疗法在非霍奇金淋巴瘤治疗中的持续研究及新用途。
Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S23-9. doi: 10.1016/j.ijrobp.2006.05.068.

本文引用的文献

1
Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial.替伊莫单抗放射性免疫疗法治疗复发或难治性非霍奇金淋巴瘤合并轻度血小板减少症患者：一项II期多中心试验
Blood. 2002 Jun 15;99(12):4336-42. doi: 10.1182/blood.v99.12.4336.
2
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.钇-90标记的替伊莫单抗放射免疫疗法与利妥昔单抗免疫疗法治疗复发或难治性低度、滤泡性或转化型B细胞非霍奇金淋巴瘤患者的随机对照试验
J Clin Oncol. 2002 May 15;20(10):2453-63. doi: 10.1200/JCO.2002.11.076.
3
Targeted therapy of cancer with radiolabeled antibodies.用放射性标记抗体对癌症进行靶向治疗。
J Nucl Med. 2002 May;43(5):693-713.
4
High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma.高剂量化疗联合放射免疫疗法及自体干细胞支持治疗复发套细胞淋巴瘤
Blood. 2002 May 1;99(9):3158-62. doi: 10.1182/blood.v99.9.3158.
5
Mantle-cell lymphoma.套细胞淋巴瘤
Lancet Oncol. 2001 Mar;2(3):141-8. doi: 10.1016/S1470-2045(00)00255-2.
6
High-dose chemotherapy with hematopoietic stem-cell transplantation for breast cancer: current status, future trends.乳腺癌的大剂量化疗联合造血干细胞移植：现状与未来趋势
Clin Breast Cancer. 2000 Oct;1(3):197-209; discussion 210. doi: 10.3816/CBC.2000.n.016.
7
High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study.采用碘-131标记的嵌合抗CD20抗体C2B8及自体干细胞支持对套细胞非霍奇金淋巴瘤进行大剂量清髓性放射免疫治疗。一项初步研究的结果
Cancer. 2002 Feb 15;94(4 Suppl):1363-72. doi: 10.1002/cncr.10307.
8
Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphoma.放射性金属标记抗体是否优于碘-131标记抗体：非霍奇金淋巴瘤患者中铜-67、碘-131和钇-90标记的Lym-1抗体的比较药代动力学和剂量学研究
Clin Lymphoma. 2000 Sep;1(2):118-26. doi: 10.3816/clm.2000.n.010.
9
Progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem-cell transplantation: changing the natural history with monoclonal antibody therapy.大剂量治疗及自体外周干细胞移植后进展性中度非霍奇金淋巴瘤：单克隆抗体治疗改变其自然病程
Clin Lymphoma. 2000 Jun;1(1):62-6. doi: 10.3816/clm.2000.n.006.
10
Radioimmunotherapy of B-cell non-Hodgkin's lymphoma.B细胞非霍奇金淋巴瘤的放射免疫疗法
Eur J Nucl Med. 2001 Nov;28(11):1725-35. doi: 10.1007/s002590100570.